Literature DB >> 8600367

Cytogenetic effects of a food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine (PhIP), and its metabolite, 2-hydroxyamino-1-methy-6-phenylimidazo[4,5-beta]pyridine (N-OH-PhIP), on human and Chinese hamster cells in vitro.

C Otsuka1, K F Miura, T Satoh, M Hatanaka, K Wakabayashi, M Ishidate.   

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine (PhIP) induced structural chromosomal aberrations (CAs) and sister-chromatid exchanges (SCEs) in human lymphocytes and human diploid fibroblasts (TIG-7) at concentrations above 12.5 microgram /ml in the presence of rat S9 mix. PhIP also elevated the frequencies of SCEs in human lymphocytes in the presence of rat S9 at concentrations above 2.0 microgram/ml with dose-dependency. A proximate form of metabolites of PhIP, 2-hydroxy-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine (N-OH-PhIP), caused CAs in human and Chinese hamster fibroblast cells in the absence of S9 mix at concentrations above 0.75 microgram/ml and 1.25 microgram/ml, respectively, which were 10 times lower than the effective concentration of PhIP. No marked differences were observed in the cytogenetic sensitivity to N-OH-PhIP between human and Chinese hamster cells, except between lymphocytes obtained from different donors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600367     DOI: 10.1016/0165-1218(95)00082-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Curcumin inhibits PhIP induced cytotoxicity in breast epithelial cells through multiple molecular targets.

Authors:  Ashok Jain; Abhilash Samykutty; Carissa Jackson; Darren Browning; Wendy B Bollag; Muthusamy Thangaraju; Satoru Takahashi; Shree Ram Singh
Journal:  Cancer Lett       Date:  2015-05-21       Impact factor: 8.679

2.  Diallyl sulfide inhibits PhIP-induced cell death via the inhibition of DNA strand breaks in normal human breast epithelial cells.

Authors:  Ayoola Aboyade-Cole; Selina Darling-Reed; Ebenezer Oriaku; Michael McCaskill; Ronald Thomas
Journal:  Oncol Rep       Date:  2008-08       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.